Indian Journal of Critical Care Medicine · 2021 · 11 citations · 13 references
MedicineInfectious DiseasesPediatricsInflammationPediatric Infectious DiseasesPediatric PulmonologyAcute Respiratory Distress SyndromeAcute Respiratory FailureImmune-mediated Inflammatory DiseasesRespiratory DiseaseCohort Study InvestigationCovid-19-associated Acute Respiratory Distress SyndromeLaboratory TestingMale-to-female RatioMultisystem Inflammatory SyndromeRetrospective Case StudySars-cov-2 InfectionSevere Acute Respiratory Syndrome
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new entity affecting a small percentage of children during the COVID-19 pandemic. MATERIALS AND METHODS: Demography, clinical, and laboratory variables of children admitted from April to September 2020 with MIS-C were studied retrospectively at eight hospitals in Delhi, India. RESULTS: = 34). Atypical presentations were hypothermia, orchitis, meningoencephalitis, demyelination, polyneuropathy, pancreatitis, and appendicitis. Ninety-four percent had laboratory evidence of SARS-CoV-2 (78.3%, seropositive and 15.8%, RT-PCR positive). The median C-reactive protein (CRP) was 136 mg/L (IQR, 63.5-212.5) and ferritin was 543 ng/mL (IQR, 225-1,127). More than 90% received immunomodulatory therapy (intravenous immunoglobulins and/or steroids) with an excellent outcome (96% survived). CRP and absolute neutrophil count (ANC) were correlated statistically with severity. CONCLUSION: MIS-C data from Delhi are presented. Rising CRP and ANC predict the severe MIS-C. HOW TO CITE THIS ARTICLE: COVID-19-associated Multisystem Inflammatory Syndrome in Children: A Multicentric Retrospective Cohort Study. Indian J Crit Care Med 2021;25(10):1176-1182.
13
Marie Pouletty, Charlotte Borocco, Naïm Ouldali et al. · Annals of the Rheumatic Diseases · 2020 · 551 citations · Full text